BD Increases US Syringe Production After FDA Warnings on China-Made Syringes
Becton, Dickinson and Company (BD) has announced its intention to increase US production of syringes after FDA recently reported that its ongoing investigation into quality issues with plastic syringes made in China were “more widespread” than originally known.
Medtronic Muses on Diabetes Management Technologies
MPO recently spoke to Ali Dianaty, SVP of product innov […]
Axena Study Underscores Incontinence Burden for Women in Sub-Saharan Africa
Axena Health, a medical technology company focused on female pelvic health, has unveiled the findings of its landmark study to understand the far-reaching impacts of urinary incontinence (UI) on women in sub-Saharan Africa.
Boston Sci Nabs FDA Approval for Agent DCB
Boston Scientific today announced FDA approval of its Agent drug-coated balloon (DCB), making it the first coronary DCB indicated for in-stent restenosis (ISR) in patients with coronary artery disease in the United States.
Philips Recalls MRI System Due to a Risk of Explosion
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death.
Getinge Purchases Healthmark Industries for $320 Million
The acquisition aims to bolster Getinge’s U.S. sterile reprocessing business.
Medtronic and Axonics Back for Final Showdown
The U.S. Patent Trial and Appeal Board made a mistake in Medtronic’s favor last year, a federal judge ruled this week.
Are Things Starting to Turn Around for Philips?
For the most part, the story of Philips has been consistent since 2021 and unfortunately, the narrative has been one of recalls and massive dips in shares. However, that story changed a bit today, when the Amsterdam-based company raised its 2023 outlook after beating consensus in the second quarter.
Medtronic Cuts Guidance After Disappointing Q223
Medtronic today announced its second quarter fiscal 2023 financial results, reporting it delivered better than expected earnings but saw disappointing revenue numbers……
Read More
3M Cuts Outlook Despite Strong 3Q22 Earnings
Overseas sales and divestitures are the culprits behind 3M cuttings its outlook for 2022, despite posting better-than-expected earnings for 3Q22. The overseas sales drop is a result of a stronger dollar……
Read More
